pounds has declined signifi cantly, as exemplifi ed by the fact that extracts from soil-derived actinomycetes have yielded unacceptably high numbers of previously described metabolites (Mincer et al., 2002) . In addition to the redundancy and associated issue of de-replication, an innovation gap has been postulated as a cause for the dramatic reduction in small molecule novelty. Even today, most microbiologists are constrained by the use of traditional cultivation methods, which primarily target previously cultured microbes ("microbial weeds").
As a result, most pharmaceutical companies no longer place an emphasis on natural-product discovery as a source of lead compounds (Walsh, 2003) .
In contrast, the marine environment is becoming increasingly appreciated as a rich and untapped reservoir of novel natural products (see Fenical, this issue). Bioactive compounds are frequently associated with marine invertebrates, including sponges, bryozoans, mollusks, and tunicates (Proksch et al., 2002) . More recently, marine microorganisms have been recognized as a productive source of novel secondary metabolites. To date, the majority of natural products of marine bacterial origin have arisen from a small number of taxonomic groups that include Streptomyces, Alteromonas, Pseudomonas, Vibrio, Agrobacterium, and the cyanobacteria (Wagner-Döbler et al., 2002; Burja et al., 2001) . Over the past decade, a consensus has developed among marine natural products chemists and chemical ecologists, who believe that most novel natural products found in extracts of marine invertebrates are synthesized, either in part or in their entirety, by the symbiotic microbes that are intimately associated with these marine metazoans.
THE EXAMPLE OF MARINE SPONGES
Marine sponges provide classic examples of microbial-macrofaunal partnerships that have been a productive source for the discovery of bioactive compounds (Faulkner, 2002) . For example, Monks et al. (2002) found that extracts of eight out of ten diff erent Brazilian sponge species exhibited anti-bacterial, anti-tumor, or anti-chemotactic activities. According to chemical ecologists, secondary metabolites are produced as part of a chemical arsenal designed to deter grazers by imparting toxicity or low palatability to the metazoan host. Th ese marine invertebrate-microbial assemblages also produce toxic compounds to prevent colonization by other non-benefi cial microbial species.
Interestingly, some of the small molecules isolated from marine metazoans display a striking resemblance to prokaryotic-borne metabolites; it has thus been suggested that the source of many of these bioactives is in fact the symbiotic microorganisms (Piel et al., 2004) .
One well-studied example is the synthesis of bryostatin-1 by the marine bryozoan, Bugula neritina, which has been directly linked to the presence of the uncultured bacterium Candidatus Endobugula sertula (Davidson et al., 2001) .
Similarly, Bugula simplex hosts the symbionts
Candidatus Endobugula glebosa, which are linked to bryostatin production (Lim and Haygood, 2004 ). Such examples demonstrate the promise of marine symbiotic microorganisms as a viable source for the discovery of novel small molecules.
MICROBIAL CULTIVATION TECHNOLOGIES
Marine agar, a cultivation medium formulated by Claude ZoBell during the 1940s (ZoBell, 1946) , has been extensively used for the isolation of marine bacteria. However, this medium contains organic carbon in concentrations much higher than those found in most natural environments; as such, strains isolated using marine agar are typically fast growing, and not always representative of cells that may play relevant roles in situ. Incubation times for the development of colonies from cells growing in rich media range from one day to one week. Mincer et al. (2002) 
HIGH THROUGHPUT CULTIVATION OF MARINE SAMPLES FROM HAWAII
Samples of the sponge, Mycale armata (Figure 1A) , were collected from Kaneohe Bay (Oahu, Hawaii), along with sediments sampled from various habitats (i.e., coral rubble, sea grass beds, a stream bed). Th e sponge and sediment samples were homogenized, and the associated microbial cells were separated using a Nycodenz cushion and diff erential centrifugation ( Figure 1B) . Th e crude cell pellets of living but uncultured microorganisms were then encapsulated in the agarose microcapsules ( Figure 1C ) as previously described (Zengler et al., 2002; Zengler et al., 2005) . Th e capsules were transferred into mini fermentation columns equipped with a 0.22 µm fi lter at the inlet and an 8 µm fi lter at the outlet to allow free-living cells to be washed out of the system while retaining the microcapsules. 
CONCLUDING REMARKS
Th e use of improved cultivation approaches for the discovery of marine natural products from marine microbes is of paramount importance for the development of new pharmaceuticals . In this case study, we have shown that HTC technology can be used to isolate novel microbial strains of microorganisms from Hawaiian marine environments, some of which produce metabolites that possess antiinfective or cytotoxic activities. Dereplication analyses are currently underway to ensure that only activities generated by novel bioactive molecules are advanced for further investigation.
We are currently expanding the applicabil- 
